# 4066
GlaxoSmithKline, makers of the Arepanrix vaccine, have ordered doctors to hold off giving any more doses from one particular batch while the company investigates a higher than normal number of allergic reactions.
The number of doses on hold are about 170,000 – a fraction of the 7.5 million doses already delivered to Canada. Six cases of anaphylaxis from this batch were reported in Manitoba, and while all victims have recovered, it has spurred further investigation.
Two reports, first this one from Bloomberg News (hat tip Florida1 at FluTrackers), and then one from Manufacturing Net, which talks of Japan’s concerns regarding this development.
Glaxo Puts Hold on Some Swine Flu Shots in Canada (Update1)
By Michelle Fay Cortez
Nov. 23 (Bloomberg) -- Canadian doctors should hold off on using a batch of GlaxoSmithKline Plc’s swine flu vaccine temporarily while the company probes reports of higher-than- expected occurrences of a side effect known as anaphylaxis, a spokeswoman for the U.K. drugmaker said today.
The batch of 172,000 doses of Arepanrix was linked to more cases of acute allergic reactions, including swollen tongues and throats, than is normally expected, spokeswoman Gwenan White said in a telephone interview. Typically, about 1 person in 100,000 will suffer such a reaction, she said.
GlaxoSmithKline Halts H1N1 Vaccinations In Canada
Manufacturing.Net - November 23, 2009WASHINGTON (Kyodo) -- British drug maker GlaxoSmithKline Plc. is suspending the use of 170,000 doses of its new H1N1 influenza vaccine in Canada given a higher-than-usual rate of reported side effects, Canadian media reported Monday.
Japan's Health, Labor and Welfare Ministry, which has a contract with the pharmaceutical firm to buy two-shot doses for 37 million people, will send a fact-finding mission to Canada by early December, health minister Akira Nagatsuma said in Tokyo.
<SNIP>
The Japanese health ministry was informed of the development by the company's Japanese unit, GlaxoSmithKline K.K., and is gathering information to determine if the problem is related to specific batches or the vaccine as a whole, ministry officials said.
Related Post:
- Hong Kong: H5N1 Vaccine Recommended For Certain Lab Workers
- Study: Adverse Events Associated With Oseltamivir Outpatient Treatment
- MMWR: Carbon Monoxide Exposures Related To Hurricane Sandy
- Canada & Switzerland Clear Novartis Flu Vaccine For Use
- Preparing For After The Storm Passes
- NPM12: A Whole Lotta Shakeouts Going On
- NPM12: Preparedness For Kids
- NIOSH: 9/5 Is N95 Day
- H3N2v: CDC Offers Advice To Fair Goers
- MMWR: Tornado Fatalities During April 2011 Outbreak
- WHO: Safety & Importance Of Thiomersal In Vaccines
- Study: Safety Of Drive-Thru Vaccination Clinics
- The Biggest Weather-Related Killer
- At The End Of My Rope
- CSL: Report On Febrile Reactions To FluVax
- CDC Statement On OIG Report On Vaccine Program For Children
- CDC Statement On Helmets & Tornadoes
- Reminder: Great Central U.S. Shakeout Today
- Branswell: PLoS One Study On Adverse Reactions To MMR Vaccine
- E. Coli: In the Raw (cookie dough)
- NIVW: Dec 4th – 10th, 2011
- Lancet: Guillain-Barré Syndrome & H1N1 Vaccine In Children
- IDSA: Flu Vaccines In Pregnancy
- BMJ: Another Pandemrix Study To Ponder
- Pediatrics: Effectiveness Of A Single Adjuvanted Pandemic Flu Shot In Children
- Canada Releases Tamiflu From National Emergency Stockpile
- Canada: FluWatch Week 52
- Canada: Another West Coast Temblor
- Haida Gwaii Quake & Tsunami Advisories
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- Ontario Confirms H1N1v Case
- EID Journal: Revisiting The `Canadian Problem’
- Alberta, Canada Issues Measles Alert
- IDSA: Educational Guidelines Lower Antibiotic Use
- Webinar: pH1N1 – H3N2 A Novel Influenza Reassortment
- North America Flu Surveillance Week 8
- North America Influenza Surveillance - Week 4
- North America: Flu Surveillance Week 2
- North America: Flu Activity Week 1
- Toronto ERs Seeing Heavy Flu Volume
- North America: H3N2 Driving Our Flu Season
- PHAC: Lessons Learned From The 2009 Pandemic
- Ontario: A Top Ten List Of Infectious Disease Threats
- Eurosurveillance: The Temporary Immunity Hypothesis
- OIE Report: Manitoba Bird Flu Identified As H5N2
- CFIA Statement On Manitoba’s Avian Flu Outbreak
- CTV Reporting Low Path H5 On Canadian Turkey Farm
- CMAJ: Comparing First And Second Pandemic Waves In Canada
- Study: Eurosurveillance On `The Canadian Problem’
- CSA White Paper: Voices From The Front Lines
- Anticipating The Flu Season Down Under
- ACP Calls For Health Care Worker Immunizations
- Branswell On Flu Vaccine Matches
- Flu Vaccine Still Available, But Spot Shortages Exist
- Study: Self-Administered Vaccines In Adults
- Egypt: A Paltry Poultry Vaccine
- Lancet: Low Flu Vaccine Effectiveness
- Hong Kong: H5N1 Vaccine Recommended For Certain Lab Workers
- AAP Endorses SAGE Recommendations Keeping Thimerosal In Vaccines
- NIVW 2012
- Study Supports Safety Of Tdap Vaccine In Older Patients
- JAMA: Waning Pertussis Vaccine Effectiveness Over Time
- Revisiting The Numbers Racket
- Of Pregnancy, Flu & Autism
- Canada & Switzerland Clear Novartis Flu Vaccine For Use
- CMAJ On Mandatory Flu Shot For HCWs
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- The UK’s Whooping Cough Outbreak
- Peter Sandman On the CCIVI Vaccine Report
- CIDRAP: The Need For `Game Changing’ Flu Vaccines
- Rhode Island Adopts New Flu Vaccination Requirements For HCPs
- Vietnam Reports Progress On New Bird Flu Vaccine
- WHO: Southern Hemisphere 2013 Flu Vaccine Composition
- NPM12: Giving Preparedness A Shot In The Arm
- Yes, We Have No Pandemic . . .
Widget by [ Iptek-4u ]